SRA awarded further $15m NIH contract
SRA International has received a $15 million outsourcing contract from the National Institutes of Health (NIH) to provide enterprise messaging and IT infrastructure support services over the next 6 years.
Archives for December 14, 2005
Outsourcing firm Patheon's 4Q encouraging
Drug production company Patheon has released its fourth-quarter results, which has revealed that profit has jumped 180 per cent despite a recent production halt at a Puerto Rican subsidiary. This bodes well for the recent manufacturing and drug...
Labs to benefit from Toxicology-On-A-Chip tool
A toxicology-on-a-chip tool, which can analyse drug candidates for toxicity before they advance to pre-clinical stages, has taken one step further towards commercialisation as the technology promises to aid laboratory researchers in weeding out...
GSK muscles in on flu vaccine makers
GlaxoSmithKline (GSK) has positioned itself to dominate the US flu vaccine market after it completed the acquisition of Canadian vaccine company ID Biomedical for $1.7 billion (€1.15 billion) last week.
SciGen establishes China manufacturing facility
SciGen are to establish a manufacturing facility in China in a response to the growing demand for the Hepatitis B (HBV) vaccine and insulin, which has reached epidemic proportions with 2 billion people having become infected with HBV at some time in...
Eli Lilly ups manufacturing capacity for 2006
US drug company, Eli Lilly, offered a more encouraging outlook than was expected forecasting an earnings growth of up to 12 per cent, a stark contrast to its struggling competitors, who also face generic competition, drug safety and regulation.
Sparks fly as REACH chemicals law approved
EU ministers yesterday agreed on a compromise version of the controversial new chemicals law, REACH, however environment groups have condemned the latest changes as a further watering down of the law in favour of industry.